#fda

Collection of fda news, found 61 news.

Investigational Oral Multiple Sclerosis Therapy Teriflunomide (*) Aubagio (R)) Significantly Reduced

Investigational Oral Multiple Sclerosis Therapy Teriflunomide (*) Aubagio (R)) Significantly Reduced

  • 6th October 2011

-            - Findings from Two-Year Pivotal Phase III TEMSO Trial ...

Delcath Announces Updated Efficacy Results From Phase 3 Trial of Chemosaturation for Melanoma Metast

Delcath Announces Updated Efficacy Results From Phase 3 Trial of Chemosaturation for Melanoma Metast

  • 26th September 2011

-      March 2011 Data Confirm Strong Treatment Effect of ...

Syneron's elure Advanced Skin Lightening(TM) Products Wins 'BEST OF BEAUTY' in Allure Magazine

Syneron's elure Advanced Skin Lightening(TM) Products Wins 'BEST OF BEAUTY' in Allure Magazine

  • 21st September 2011

-            - elure Advanced Skin Lightening Products captures the ...

More Patients with Type 2 Diabetes Reach HbA[1c] Target with Apidra(R) on top of Lantus(R)

More Patients with Type 2 Diabetes Reach HbA[1c] Target with Apidra(R) on top of Lantus(R)

  • 13th September 2011

-            - First Randomized Controlled Trial to Show That Basal Plus ...

Synthes and Lilly Sign Development and Collaboration Agreement

Synthes and Lilly Sign Development and Collaboration Agreement

  • 10th June 2011

-        Synthes, Inc. (SIX: SYST.VX) and Eli Lilly and Company (NYSE: LLY) today ...

Edison Pharmaceuticals to Provide Expanded Access to EPI-743 for Mitochondrial Disease

Edison Pharmaceuticals to Provide Expanded Access to EPI-743 for Mitochondrial Disease

  • 8th June 2011

-FDA allows use of investigational new drug for life-threatening indications     Edison ...

Edison Pharmaceuticals Announces FDA Grants EPI-743 Orphan Drug Designation

Edison Pharmaceuticals Announces FDA Grants EPI-743 Orphan Drug Designation

  • 8th June 2011

-Designation covers inherited respiratory chain diseases of the mitochondria    Edison Pharmaceuticals, ...

Four Phase 3 Efficacy and Safety Studies of Ingenol Mebutate

Four Phase 3 Efficacy and Safety Studies of Ingenol Mebutate

  • 7th June 2011

-        - NOT INTENDED FOR US MEDIA    - Ingenol Mebutate is an ...

Sanofi's Investigational Semuloparin in Cancer Patients Initiating Chemotherapy Shows a 64 % Risk Re

Sanofi's Investigational Semuloparin in Cancer Patients Initiating Chemotherapy Shows a 64 % Risk Re

  • 6th June 2011

-        - Results of Phase III SAVE-ONCO Study Selected for "Best of ASCO 2011" ...

Thailand Lakukan Pemeriksaan Makanan Impor dari Jepang

Thailand Lakukan Pemeriksaan Makanan Impor dari Jepang

  • 25th March 2011

Badan Obat dan Makanan Thailand (FDA) telah memerintahkan pemeriksaan acak bagi segala makanan dan meminta importir ...

MASEP Infini Announces U.S. FDA 510(k) Clearance of State-of-the-art, Non-invasive Stereotactic Neur

MASEP Infini Announces U.S. FDA 510(k) Clearance of State-of-the-art, Non-invasive Stereotactic Neur

  • 24th March 2011

-     The New Infini(TM) System Provides Healthcare Systems with an Alternative System for ...

US blocks milk, produce from Japan near nuclear plant

US blocks milk, produce from Japan near nuclear plant

  • 23rd March 2011

The United States will block imports of milk and fresh produce from areas of Japan near a crippled nuclear power ...

Phase III Results Show Mirabegron Improves Key OAB Symptoms

Phase III Results Show Mirabegron Improves Key OAB Symptoms

  • 21st March 2011

-        - First Presentations of European-Australian and North American Phase III Trials ...

Accumetrics Announces Publication of GRAVITAS Primary Results in JAMA

Accumetrics Announces Publication of GRAVITAS Primary Results in JAMA

  • 16th March 2011

-Evaluation of Alternative Treatment Strategies Incorporating Platelet Function Testing Recommended    ...

Accumetrics Signs Development & Supply Agreement With Portola Pharmaceuticals, Inc.

Accumetrics Signs Development & Supply Agreement With Portola Pharmaceuticals, Inc.

  • 3rd March 2011

-VerifyNow System to be used in Drug Developer's Clinical Studies    Accumetrics, Inc., a privately-held ...